Effect of chondroitin sulphate C on the in vitro and in vivo chondrogenesis of mesenchymal stem cells in crosslinked type II collagen scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 8, 2013, Pages 665-672

  Chen, Wei Chuan ^a   Wei, Yu Hong ^b   Chu, I Ming ^a   Yao, Chao Ling ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

Chondrogenesis; Chondroitin sulphate C; in vivo defect repair; Mesenchymal stem cells; Microenvironment; Type II collagen

Indexed keywords

CARTILAGE; COLLAGEN; FLOWCHARTING; GENE EXPRESSION; REPAIR; SCAFFOLDS (BIOLOGY); STEM CELLS; SULFUR COMPOUNDS;

CHONDROGENESIS; CHONDROITIN SULPHATE C; CHONDROITINSULFATE; DEFECT REPAIR; GENES EXPRESSION; IN VIVO DEFECT REPAIR; IN-VIVO; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; TYPE II COLLAGENS;

CELL CULTURE;

AGGRECAN; CHONDROITIN 6 SULFATE; COLLAGEN TYPE 2;

ANIMAL CELL; ARTICLE; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RECEPTOR DOWN REGULATION;

EID: 84880697732     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1463     Document Type: Article

References (32)

1. Bosnakovski D, Mizuno M, Kim G, et al. 2006; Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng 93: 1152-1163.
2. Cao H, Xu SY. 2008; EDC/NHS-crosslinked type II collagenchondroitin sulfate scaffold: characterization and in vitro evaluation. J Mater Sci Mater Med 19: 567-575.
3. Caplan AI, Goldberg VM. 1999; Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop Relat Res 367: S12-16.
4. Chang CH, Kuo TF, Lin CC, et al. 2006; Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36weeks. Biomaterials 27: 1876-1888.
5. Chen WC, Yao CL, Wei YH, et al. 2011a; Evaluating osteochondral defect repair potential of autologous rabbit bone marrow cells on type II collagen scaffold. Cytotechnology 63: 13-23.
6. Chen WC, Yao CL, Wei YH, et al. 2011b; Compare the effects of chondrogenesis by culture of human mesenchymal stem cells with various types of chondroitin sulfate C. J Biosci Bioeng 111: 226-231.
7. Chen WC, Wei WH, Huang JB, et al. 2011c; Biological effects of oligosaccharide chondroitin sulfate C on human articular chondrocytes. Biomed Eng Appl Basis Commun 23: 245-252.
8. Choocheep K, Hatano S, Takagi H, et al. 2010; Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem 285: 21114-21125.
9. Fox BA, Stephens MM. 2009; Glucosamine/chondroitin/primorine combination therapy for osteoarthritis. Drugs Today (Barc) 45: 21-31.
10. Guo CA, Liu XG, Huo JZ, et al. 2007; Novel gene-modified tissue engineering of cartilage using stable transforming growth factor-β1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng 103: 547-556.
11. Haasper C, Zeichen J, Meister R, et al. 2008; Tissue engineering of osteochondral constructs in vitro using bioreactors. Injury 39: S66-76.
12. Irie Y, Mizumoto H, Fujino S, et al. 2008; Reconstruction of cartilage tissue using scaffold-free organoid culture technique. J Biosci Bioeng 105: 450-453.
13. Kao IT, Yao CL, Chang YJ, et al. 2008; Chondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemically synthesized thermoreversible polymer. Chin J Physiol 51: 252-258.
14. Ko CS, Wu CH, Huang HH, et al. 2007; Genipin cross-linking of type II collagen-chondroitin sulfate-hyaluronan scaffold for articular cartilage therapy. J Med Biol. Eng 27: 7-14.
15. Ko CS, Huang JP, Huang CW, et al. 2009; Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering. J Biosci Bioeng 107: 177-182.
16. Lind M, Larsen A, Clausen C, et al. 2008; Cartilage repair with chondrocytes in fibrin hydrogel and MPEG polylactide scaffold: an in vivo study in goats. Knee Surg Sports Traumatol Arthrosc 16: 690-698.
17. Makaya K, Terada S, Ohgo K, et al. 2009; Comparative study of silk fibroin porous scaffolds derived from salt/water and sucrose/hexafluoroisopropanol in cartilage formation. J Biosci Bioeng 108: 450-453.
18. Maroudas A. 1979; Physiochemical properties of articular cartilage. In Adult Articular Cartilage, 2nd edn, Freeman MAR (ed.). Pitman Medical: Kent, UK; 215-290.
19. McAlindon TE, LaValley MP, Gulin JP, et al. 2000; Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. J Am Med Assoc 283: 1469-1475.
20. Na K, Choi SJ, Kim S, et al. 2007; Enhancement of cell proliferation and differentiation by combination of ascorbate and dexamethasone in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biotechnol Lett 29: 1453-1457.
21. Park KH, Kim H, Moon S, et al. 2009a; Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J Biosci Bioeng 108: 530-537.
22. Park KH, Na K. 2008; Effect of growth factors on chondrogenic differentiation of rabbit mesenchymal cells embedded in injectable hydrogels. J Biosci Bioeng 106: 74-79.
23. Park KH, Park W, Na K. 2009b; Synthetic matrix containing glucocorticoid and growth factor for chondrogenic differentiation of stem cells. J Biosci Bioeng 108: 168-173.
24. Peterson L, Brittberg M, Kiviranta I, et al. 2002; Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30: 2-12.
25. Richy F, Bruyere O, Ethgen O, et al. 2003; Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 163: 1514-1522.
26. Roughley P, Martens D, Rantakokko J, et al. 2006; The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. Eur Cell Mater 1: 1-7.
27. Tuan RS. 2004; Biology of developmental and regenerative skeletogenesis. Clin Orthop Relat Res 427: S105-117.
28. Uygun BE, Stojsih SE, Matthew HW. 2009; Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng A 15: 3499-3512.
29. Varghese S, Hwang NS, Canver AC, et al. 2008; Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol 27: 12-21.
30. Wendt D, Jakob M, Martin I. 2005; Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturing. J Biosci Bioeng 100: 489-494.
31. Yan H, Yu C. 2007; Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy 23: 178-187.
32. Yun K, Moon HT. 2008; Inducing chondrogenic differentiation in injectable hydrogels embedded with rabbit chondrocytes and growth factor for neocartilage formation. J Biosci Bioeng 10: 122-126.